Most conversations about quantum computing suffer from the same problem. They collapse three distinct timelines into one vague future, somewhere between “soon” and “transformative”, leaving business leaders either dismissing the technology as overhyped or waiting passively for a breakthrough that may not arrive in the form they expect. The Quantum Edge panel at Rotman, featuring researchers, founders, and policy voices from across Canada’s quantum ecosystem, offered something more useful: a way to separate the clocks.
There are three of them. Each one demands a different response.
The first clock is already running
Post-quantum cryptography is not a future problem. It is a present one. The threat is not that a quantum computer will break your encryption tomorrow. The threat is that adversaries are harvesting encrypted data today, storing it, and waiting for quantum hardware powerful enough to decrypt it later. For life sciences companies, the data at risk is not abstract. It includes clinical trial results, partnership agreements, and proprietary compound libraries, assets whose value depends entirely on remaining confidential for years or decades.
Canada’s federal government has already internalized this. A post-quantum migration roadmap was released in 2024, with the first compliance timelines landing at the end of April 2026. For business leaders, the action is concrete: audit your most sensitive data, understand your exposure window, and begin the transition to post-quantum cryptographic standards. The term the panel used was crypto-agile, meaning systems designed to swap cryptographic protocols without rebuilding the entire infrastructure.
One panelist put the stakes in terms that should reframe how every executive thinks about this:
“Rather than framing things as a question of when will the quantum computer be here… it is really more of a question of how long you need your data to be secure.”
The second clock is ticking for strategists and operators
The exponential speed-up that defines true quantum advantage, the ability to solve problems that would take classical computers thousands of years, is not here yet. But that does not mean quantum computing has no economic value today. It means the value looks different than the headline version.
The panel offered a clarifying example. If a quantum computer can produce a solution in seconds that a classical computer would take an hour to produce, the quantum computer wins commercially, even without exponential advantage. In fast-moving markets, timeliness is the product. Portfolio rebalancing was cited as the clearest near-term case. It is a discrete optimization problem with exponentially growing complexity, and it is time-sensitive in exactly the way that makes modest speed-ups commercially decisive. When market conditions shift faster than a classical solver can recompute, the answer you get in an hour is not just slower. It is wrong.
For life sciences, the analogue sits in clinical operations, supply chain optimization, and trial design. Companies do not need to wait for fault-tolerant quantum hardware to begin extracting value. OTI Lumionics, a materials discovery company and Creative Destruction Lab alumnus, has been running experiments on current quantum hardware. This is not because the hardware is ready to outperform classical computers at scale, but because mapping problems to quantum architecture today generates algorithmic insights that compound over time. The short-term gain is not a quantum solution. It is a better classical solution, informed by quantum thinking.
“Companies are already experimenting with quantum hardware, creating short-term value even in the nascent stage of the technology.”
The third clock is the one most people picture when they hear “quantum.”
Error-corrected, fault-tolerant quantum computers capable of exact molecular simulation are the long-term prize. They will not arrive next year. However, the economic logic for when they do is compelling enough that positioning decisions made today will determine who captures the value.
The fundamental problem in computational chemistry is simulating molecules in their lowest energy state. This is how new drugs and materials are discovered. It is also, classically, intractable. The complexity grows exponentially with the number of interacting particles, which means that beyond a certain molecular size, the best classical methods are approximations. Quantum computers, once they operate at sufficient scale with error correction, can run these simulations with numerical exactness.
The commercial consequence is not incremental. A pharma company that spends fifteen cents of every revenue dollar on R&D, can compress that to ten cents through quantum-accelerated simulation. It does not just cut costs, it runs more experiments, generates more candidates, and gets to clinical trials faster. Quantum does not replace the scientist. It eliminates the computational ceiling that currently limits how many hypotheses a scientist can test.
The stakes for Canada
Canada punches above its weight in quantum. By company count per capita, it ranks first in the world. The research is serious, the talent is real, and institutions like Creative Destruction Lab have helped build a startup ecosystem that draws international attention.
But recognition is not the same as value capture.
The honest read from the panel is that Canada excels at creating quantum companies and struggles to scale them. The commercialization gap is not a secret. Private risk capital is thin. Procurement pipelines that could anchor early revenue for domestic firms are slow. And the supply chains needed to manufacture quantum hardware at scale do not yet exist here.
The consequence is predictable. Companies get approached by US defense agencies with financing offers, foreign acquirers make compelling cases, talent follows the money, and value that was created in Canada ends up somewhere else.
The Multiverse Computing example pointed at a different path. Spanish and Basque government investors backed the company early, not purely for financial return but for strategic access to foundational technology. That anchor helped close a larger private round. It is not a complicated model. It just requires governments and institutions to act like strategic investors rather than passive supporters.
One panelist did not mince words about where responsibility sits.
“If Canada fails it is because of Canadians. The only people getting in our way, is us.”
What to do with three clocks
The framework is not complicated. Clock one is a risk management problem, and it has a deadline. Clock two is a competitive intelligence problem, and it rewards early experimentation. Clock three is a positioning problem, and it rewards patience combined with deliberate investment in readiness.
The leaders who will benefit most from quantum computing are not the ones waiting for a single breakthrough moment. They are the ones who have already decided which clock they are watching and built a plan around it.
Leave a Reply